BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba and Koppert Extend Distribution Agreement for Biofungicides

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Chassieu, France - Amoéba, a greentech company focused on natural microbiological solutions, and Koppert, a leader in biological crop protection, have extended their distribution agreement for one more year, now until June 2031. This extension covers Amoéba's innovative biofungicide targeting vineyards and vegetables in 18 European countries and the US.

The two firms are committed to accelerating the commercial success of products such as TIAGAN and YAZU, which have been prominently featured at recent events like GreenTech Europe. The partnership extension follows the marketing approval given in France for AXPERA, with expectations of further European authorizations.

Executives from both companies express optimism about meeting the high demand and expanding market access, reaffirming their long-term collaboration to make these eco-friendly solutions available to more growers.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news